Figure 4From: Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis Cost-effectiveness acceptability curves based on Monte Carlo simulations of combination treatments for 70 year old men (efficacy on heart failure and angina not included) (for simplicity; only curves with probability higher than 3% included in the graph).Back to article page